Leveragen
Business Services · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2f Gill St, Woburn, Massachusetts, 01801...Phone Number
(508) 319-9988Website
www.leveragen.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Leveragen
Leveragen is a Boston-based biotech company specializing in genetic engineering and the development of next-generation antibody platforms. The company focuses on creating designer mutations for genetic modeling to facilitate the discovery of novel diagnostics and therapeutics. Leveragen's intended clients include pharmaceutical and biotech companies seeking advanced solutions for antibody discovery and development. By leveraging its expertise in genetic engineering, Leveragen aims to transform the landscape of therapeutic development.Explore more
Leveragen Org Chart
CN
Manager, Strategic Marketing
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Leveragen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Leveragen, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Leveragen has new funding data
Congratulate Masked Content for being promoted to Masked Content at Leveragen
Check if Leveragen has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if Leveragen had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Leveragen is spiking on competitors!
Earning: See what the market has to say on Leveragen recently announced quarterly report
Product Launch: Get notified when Leveragen launches new products
Recommended Actions
Find VP level buyers at Leveragen
Find 2 more new buyers
Compare Similar Companies to Leveragen
Compare insights from companies similar to Leveragen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Leveragen is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Leveragen is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Leveragen.
Leveragen Tech Stack
A closer look at the technologies used by Leveragen
See more technologies
Most Recent Scoops
Partnership
Partnership, Research & Development, Medical Research, Pharmaceuticals
Partnership
Project
Partnership, Product Development, Research & Development, Intellectual Property, Legal Affairs, Bioengineering, Medical Research, Pharmaceuticals
Event
will be attending the PEGS Boston Summit 2023 conference as an exhibitor. The event will occur from May 15 to May 19, 2023.
Events
Event
Leveragen News & Media
Leveragen Announces Strategic Collaboration with Moonlight Bio to Advance T Cell Therapies Using Proprietary Fully Human Single-Domain Antibody Technology
WOBURN, Mass.--(BUSINESS WIRE)--Leveragen Inc., a Boston-based biotech company specializing in next-generation genetic models for antibody discovery, today announced a strategic collaboration with Moonlight Bio, a Seattle-based biotech company pioneering advanced T cell therapies. This partnership aims to develop cutting-edge T cell therapies to address some of the most challenging and difficult-to-treat cancers. The collaboration integrates Leveragen’s proprietary Singularity Sapiens Mouse plaDPBIO and Leveragen Announce Strategic Partnership to Advance Antibody Discovery
BOSTON--(BUSINESS WIRE)--Dapu Biotechnology (DPBIO), an industry leader in droplet microfluidic technology, and Leveragen, Inc., a Boston-based biotech developing advanced genetic models for antibody discovery, have announced a strategic partnership to accelerate innovations in antibody drug development. The collaboration brings together DPBIO’s Cytospark™ droplet microfluidic single-B cell antibody discovery platform and Leveragen’s Singularity Sapiens Mouse, a next-generation genetic model foAntibody Solutions Becomes Approved CRO for Leveragen’s Singularity Sapiens Mouse
SANTA CLARA, Calif.--(BUSINESS WIRE)--Antibody Solutions, a leading provider of custom antibody services to the biopharmaceutical market, announced today that it has been approved as a contract research organization (CRO) for use of the next-generation fully human single-domain antibody platform – the Singularity Sapiens Mouse – by Boston-based Leveragen, Inc. The agreement allows Antibody Solutions to pursue antibody discovery initiatives using Leveragen mice for clients who have licensed theLeveragen Announces Collaboration Agreement with Moderna Using Proprietary Fully Human Single Domain Antibody Technology to Advance Therapeutics
WOBURN, Mass.--(BUSINESS WIRE)-- #leveragen--Leveragen, Inc., a Boston-based early-stage biotech company developing next-generation genetic models for antibody discovery, announced today that it has entered a multi-target research, option and license agreement with Moderna, Inc. Under the agreement, Leveragen will employ its proprietary fully human single domain antibody discovery platform to generate a panel of optimized binding modules against therapeutic targets selected by Moderna. Moderna w
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Leveragen
Sign Up For FreeTo access detailed company insights
Leveragen is a Boston-based biotech company specializing in genetic engineering and the development of next-generation antibody platforms. The company focuses on creating designer mutations for genetic modeling to facilitate the discovery of novel diagnostics and therapeutics. Leveragen's intended clients include pharmaceutical and biotech companie... Read More
